Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
May 14, 2024, 09:19 |
Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 13, 2024, 15:32 |
Blog
Vivek Subbiah: Charting the Ethical Course
Vivek Subbiah shared a post on X: "Just in time. Published for your quick weekend reading…
May 13, 2024, 12:27 |
Insight
Vivek Subbiah: Interpreting and integrating genomic tests results in clinical cancer care
Vivek Subbiah shared on X: "Published now in the May/ June issue 2024 at CA:…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 13, 2024, 07:25 |
Blog
Partnership between Ligand Pharmaceuticals and Agenus
Ligand Pharmaceuticals shared on their LinkedIn page: "We are excited to announce our latest royalty…
May 13, 2024, 05:26 |
Blog
AACR - Joint workshop on Trial Designs for Treatment Regimens with Multiple Phases
AACR shared a post on X: "AACR Past President Elizabeth M. Jaffee and FDA oncology's Harpreet…
May 12, 2024, 14:20 |
Blog
Andrea Suárez: Attended the Miami Precision Medicine Patient Symposium
Andrea Suárez, a patient advocate, shared a post on X: "Attended the Miami Precision Medicine…
May 12, 2024, 07:27 |
Drugs
Tanja Obradovic summarizes the latest news on immunotherapy with chemoradiation NSCLC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: “Based on what…
May 11, 2024, 11:32 |
Blog
Vivek Subbiah: Future of early-phase drug development and precision medicine is bright at Gustave Roussy Cancer Center!
Vivek Subbiah shared a post by Adrien Mouren, on X and added: "Future of early-phase…
May 11, 2024, 11:23 |
Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
62
63
64
65
66
All:
950
Posts:
631 - 640
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube